Do speed-endurance sessions every second day beat every fourth?
In 18 trained runners, 20 sessions every 2nd or 4th day gave no further 10-km gain after 10 familiarisation sessions; exhaustion time rose in both. B-, abstract.
Skovgaard, Almquist and Bangsbo asked whether trained runners who already use speed-endurance training (SET) gain more by doing it more often.
After a familiarisation period (FAM) of 10 SET sessions, 18 runners (14 men, 4 women; VO2max 57.3 ± 3.4) completed 20 more sessions either every fourth day (low frequency, LF, n = 7; 2 per 8 days) or every second day (high frequency, HF, n = 11; 4 per 8 days).
During FAM, 10-km performance improved by about 3.5%, time to exhaustion at 90% of vVO2max lengthened 15% (HF) and 22% (LF), running economy improved, VO2max did not change, and muscle NHE1, citrate synthase and phosphofructokinase rose.
During the intervention period (INT), 10-km performance did not change further in either group, while time to exhaustion lengthened a further 12% (HF) and 16% (LF); VO2max, economy and the two enzymes did not change; NKAβ1 rose in both groups, FXYD1 and SERCA1 expression and FXYD1 activity rose in HF, and SERCA2 fell in LF.
The authors conclude that increased or maintained SET frequency improves short-term exercise capacity but not 10-km performance. Our reading: with REF-005 and REF-1293, one more trial in trained athletes where doing quality sessions more often did not improve the endurance outcome; the abstract gives too little to weigh it further.
Protocol
Key Results
| Outcome | FAM (10 sessions, all runners) | INT, every 2nd day (HF, n = 11) | INT, every 4th day (LF, n = 7) |
|---|---|---|---|
| 10-km performance | improved ~3.5% (P < 0.05) | no further change | no further change |
| Time to exhaustion at 90% vVO2max | +15% (HF) and +22% (LF) (P < 0.05) | further +12% (P < 0.05) | further +16% (P < 0.05) |
| Running economy | improved (P < 0.05) | unchanged | unchanged |
| VO2max | unchanged | unchanged | unchanged |
| Citrate synthase, PFK maximal activity | increased | unchanged | unchanged |
| Muscle proteins | NHE1 up | NKAβ1 up; FXYD1, SERCA1 expression and FXYD1 activity up | NKAβ1 up; SERCA2 down |
Mechanisms
Practical Application
Limitations
How this entry was checked and changed
n = 18 trained runners in groups of 11 and 7, read from the abstract only (full text not open). A small two-group study (B); held at B- as an abstract-only small study with key methods missing — the session format, allocation, the length of each arm and the between-group statistics are not in the abstract